Evome Medical Technologies Inc.
LNDZF
$0.0041
-$0.0027-39.71%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 49.51% | 47.50% | 72.65% | -621.67% | 368.24% |
| Total Depreciation and Amortization | -180.80% | -20.72% | -18.17% | 4.18% | 2.64% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -69.59% | 561.19% | -94.77% | 502.67% | -609.97% |
| Change in Net Operating Assets | 555.10% | -123.51% | 65.71% | 257.52% | -14.47% |
| Cash from Operations | -42.62% | 602.67% | -155.76% | 1,131.94% | 90.34% |
| Capital Expenditure | -- | 100.00% | -261.93% | 125.81% | -115.82% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 100.00% | -261.93% | 125.81% | 93.25% |
| Total Debt Issued | 775.74% | -- | -- | -72.09% | -472.06% |
| Total Debt Repaid | -0.03% | -971.14% | -60.88% | -119.23% | 284.78% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 35.90% | -908.03% | 83.32% | -7,814.29% | 108.59% |
| Foreign Exchange rate Adjustments | -25.98% | 47.82% | -20.23% | 262.83% | -143.51% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -59.55% | 220.80% | -416.95% | 61.76% | 84.95% |
